Ovarian cancer outcomes endometrial cancer vulvar neoplasms. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Cell Line, Tumor Endometrium Tumor Cells, Cultured Neoplastic Stem Cells Ovary Epithelial Cells

Organisms2

Mice, Nude Mice, SCID

Diseases66

Vulvar Neoplasms Endometrial Neoplasms Ovarian Neoplasms Breast Neoplasms Carcinoma, Endometrioid Neoplasms, Glandular and Epithelial Neoplasms Prostatic Neoplasms Cystadenocarcinoma, Serous Neoplasm Invasiveness Neoplasm Recurrence, Local Lung Neoplasms Pancreatic Neoplasms Carcinoma Adenocarcinoma, Clear Cell Adenocarcinoma Neoplasm Metastasis Genetic Predisposition to Disease Disease Progression Uterine Neoplasms Colonic Neoplasms Colorectal Neoplasms Stomach Neoplasms Endometrial Hyperplasia Urinary Bladder Neoplasms Adenocarcinoma, Mucinous Genital Neoplasms, Female Uterine Cervical Neoplasms Neoplasms, Multiple Primary Neoplasms, Cystic, Mucinous, and Serous Peritoneal Neoplasms Neoplasms, Second Primary Cystadenocarcinoma, Papillary Colorectal Neoplasms, Hereditary Nonpolyposis Skin Neoplasms Carcinoma, Squamous Cell Adenocarcinoma, Papillary Cell Transformation, Neoplastic Liver Neoplasms Cystadenocarcinoma Carcinoma, Non-Small-Cell Lung Ascites Rectal Neoplasms Neoplasms, Hormone-Dependent Kidney Neoplasms Thyroid Neoplasms Precancerous Conditions Neovascularization, Pathologic Gastrointestinal Neoplasms Neoplasms, Radiation-Induced Bone Neoplasms Carcinoma, Papillary Esophageal Neoplasms Cystadenocarcinoma, Mucinous Mouth Neoplasms Head and Neck Neoplasms Neoplasms, Experimental Neoplastic Syndromes, Hereditary Mixed Tumor, Mullerian Fallopian Tube Neoplasms Microsatellite Instability Testicular Neoplasms Cystadenoma, Serous Carcinoma, Pancreatic Ductal Adenoma Recurrence

Chemicals and Drugs45

Tumor Markers, Biological CA-125 Antigen Neoplasm Proteins Antineoplastic Agents Receptors, Estrogen DNA, Neoplasm Paclitaxel Cisplatin Tamoxifen Prostate-Specific Antigen RNA, Messenger Estrogens Receptors, Progesterone Cancer Vaccines Antigens, Neoplasm BRCA2 Protein Antineoplastic Agents, Hormonal RNA, Small Interfering BRCA1 Protein Antineoplastic Agents, Phytogenic Tumor Suppressor Protein p53 Receptor, erbB-2 Progestins Epididymal Secretory Proteins Contraceptives, Oral Carboplatin Tumor Suppressor Proteins Antibodies, Monoclonal RNA, Neoplasm PTEN Phosphohydrolase Nuclear Proteins DNA-Binding Proteins MicroRNAs Estrogen Receptor alpha Estrogen Antagonists Proto-Oncogene Proteins Proto-Oncogene Proteins c-akt Transcription Factors Receptor, Epidermal Growth Factor Anticarcinogenic Agents Fluorouracil Antigens, Tumor-Associated, Carbohydrate Adaptor Proteins, Signal Transducing Estrogen Receptor Modulators Selective Estrogen Receptor Modulators

Analytical, Diagnostic and Therapeutic Techniques and Equipment73

Treatment Outcome Prognosis Neoplasm Staging Early Detection of Cancer Survival Analysis Risk Factors Retrospective Studies Survival Rate Follow-Up Studies Prospective Studies SEER Program Cohort Studies Registries Disease-Free Survival Kaplan-Meier Estimate Gene Expression Profiling Risk Assessment Case-Control Studies Risk Incidence Chemotherapy, Adjuvant Immunohistochemistry Multivariate Analysis Antineoplastic Combined Chemotherapy Protocols Reverse Transcriptase Polymerase Chain Reaction Hysterectomy Odds Ratio Prostatectomy Oligonucleotide Array Sequence Analysis Logistic Models Predictive Value of Tests Proportional Hazards Models Xenograft Model Antitumor Assays Clinical Trials as Topic Mammography Blotting, Western Sensitivity and Specificity Reproducibility of Results Neoplasm Grading Radiotherapy Mastectomy Neoplasm Transplantation Combined Modality Therapy Questionnaires Salpingectomy Genetic Testing Polymerase Chain Reaction Tissue Array Analysis Confidence Intervals Transplantation, Heterologous Estrogen Replacement Therapy Pregnancy Outcome Drug Screening Assays, Antitumor Immunoenzyme Techniques Tumor Burden Molecular Targeted Therapy DNA Mutational Analysis Transfection Body Mass Index Lymph Node Excision Randomized Controlled Trials as Topic Gene Knockdown Techniques Neoplasms, Experimental Flow Cytometry Radiotherapy, Adjuvant Drug Administration Schedule Mass Screening Biopsy Hormone Replacement Therapy Gynecologic Surgical Procedures Models, Biological Chi-Square Distribution Reproductive History

Psychiatry and Psychology1

Phenomena and Processes51

Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Genes, BRCA1 Risk Drug Resistance, Neoplasm Odds Ratio Mutation Time Factors Germ-Line Mutation Cell Proliferation Postmenopause Genes, BRCA2 DNA Methylation Genotype Sensitivity and Specificity Apoptosis Cell Survival Polymorphism, Genetic Cell Growth Processes Down-Regulation Gene Silencing Dose-Response Relationship, Drug Pregnancy Outcome Cell Division Signal Transduction Cell Movement Genes, Tumor Suppressor Cell Cycle Menopause Promoter Regions, Genetic Up-Regulation Parity Transfection Body Mass Index RNA Interference Premenopause Gene Expression Base Sequence Alleles Diet Genes, Neoplasm Microsatellite Repeats Genes, p53 Heterozygote Phenotype Microsatellite Instability Loss of Heterozygosity Drug Synergism Chi-Square Distribution Phosphorylation Pregnancy

Disciplines and Occupations3

Outcome Assessment (Health Care)Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life National Cancer Institute (U.S.)Socioeconomic Factors

Humanities1

Quality of Life

Information Science7

Survival Rate SEER Program Registries Incidence Questionnaires Base Sequence Molecular Sequence Data

Named Groups4

European Continental Ancestry Group African Americans Survivors Hispanic Americans

Health Care39

Treatment Outcome Survival Analysis Risk Factors Retrospective Studies Survival Rate Follow-Up Studies Prospective Studies SEER Program Cohort Studies Registries Outcome Assessment (Health Care)Disease-Free Survival Kaplan-Meier Estimate Risk Assessment Case-Control Studies Risk Incidence Multivariate Analysis Odds Ratio Logistic Models Predictive Value of Tests Proportional Hazards Models Age Factors Clinical Trials as Topic Sensitivity and Specificity Reproducibility of Results Questionnaires Genetic Testing Confidence Intervals Healthcare Disparities National Cancer Institute (U.S.)Socioeconomic Factors Parity Body Mass Index Randomized Controlled Trials as Topic Mass Screening Chi-Square Distribution Reproductive History Confounding Factors (Epidemiology)

Geographicals4

United States Sweden China Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Vulvar Neoplasms Endometrial Neoplasms Ovarian Neoplasms Breast Neoplasms Carcinoma, Endometrioid Treatment Outcome Prognosis Neoplasms, Glandular and Epithelial Neoplasms Neoplasm Staging Early Detection of Cancer Prostatic Neoplasms Tumor Markers, Biological Cystadenocarcinoma, Serous Gene Expression Regulation, Neoplastic Survival Analysis Risk Factors Retrospective Studies Neoplasm Invasiveness Cell Line, Tumor Survival Rate Neoplasm Recurrence, Local Follow-Up Studies Lung Neoplasms CA-125 Antigen United States Pancreatic Neoplasms Prospective Studies Carcinoma SEER Program Cohort Studies Registries Outcome Assessment (Health Care)Disease-Free Survival Neoplasm Proteins Kaplan-Meier Estimate Gene Expression Profiling Adenocarcinoma, Clear Cell Adenocarcinoma Risk Assessment Case-Control Studies Mice, Nude Antineoplastic Agents Neoplasm Metastasis Genetic Predisposition to Disease Disease Progression Genes, BRCA1 Risk Drug Resistance, Neoplasm Uterine Neoplasms Colonic Neoplasms Colorectal Neoplasms Stomach Neoplasms Endometrial Hyperplasia Incidence Receptors, Estrogen Chemotherapy, Adjuvant Urinary Bladder Neoplasms Adenocarcinoma, Mucinous Immunohistochemistry Multivariate Analysis Genital Neoplasms, Female Antineoplastic Combined Chemotherapy Protocols DNA, Neoplasm Reverse Transcriptase Polymerase Chain Reaction Hysterectomy Odds Ratio Paclitaxel Prostatectomy Oligonucleotide Array Sequence Analysis Logistic Models Mutation Cisplatin Time Factors Predictive Value of Tests Proportional Hazards Models Tamoxifen Xenograft Model Antitumor Assays Prostate-Specific Antigen European Continental Ancestry Group RNA, Messenger Uterine Cervical Neoplasms Neoplasms, Multiple Primary Age Factors Neoplasms, Cystic, Mucinous, and Serous Germ-Line Mutation Peritoneal Neoplasms Endometrium Cell Proliferation African Americans Postmenopause Neoplasms, Second Primary Clinical Trials as Topic Estrogens Quality of Life Receptors, Progesterone Genes, BRCA2 Mammography DNA Methylation Blotting, Western

No FAQ available that match "ovarian cancer outcomes endometrial cancer vulvar neoplasms"